Prostamax

Prostamax (Lys-Glu-Asp-Pro, KEDP) is a synthetic tetrapeptide (MW ~487.5 g/mol) from the Khavinson bioregulatory peptide family, designed as a prostate-specific bioregulator. It is proposed to restore prostate tissue homeostasis, reduce benign prostatic hyperplasia (BPH) symptoms, and normalize prostate function in aging men. Published primarily in Russian urology literature.

Category: Hormonal / Anti-Aging. Evidence rating: D (animal/preclinical only).

Clinical status: Russian clinical studies in elderly men with BPH. Not validated in Western trials.

Prostamax is proposed to modulate gene expression in prostatic epithelial and stromal cells, reducing proliferative signaling while maintaining normal secretory function. In animal models, it reportedly reduced prostate weight, improved urodynamic parameters, and normalized PSA levels. The…

Safety considerations: Reported as well-tolerated; No serious adverse events in published literature; Simple tetrapeptide with expected low toxicity.

Reviewed by the PeptideAtlas Editorial Team.

Prostamax — measured properties

Amino-acid sequenceLys-Glu-Asp-Pro (KEDP)
Molecular weight~487.5 g/mol
Half-life~20-40 minutes
Production methodsynthetic
Anti-doping statusnot-listed
US regulatory statusResearch peptide. Not FDA-approved.

Related peptides: Testagen.

Frequently asked questions

Can Prostamax treat prostate enlargement?

Prostamax has limited Russian clinical data suggesting symptom improvement in BPH. It is not a substitute for established BPH treatments (alpha-blockers, 5-alpha reductase inhibitors, surgery). Consult a urologist for prostate issues.

What is PROSTAMAX?

Prostamax is a bioregulator peptide from the Khavinson family, researched for prostate health and urological support. Part of the Russian peptide bioregulator tradition targeting specific organ systems.

What are the research benefits of PROSTAMAX?

PROSTAMAX has been studied for: Prostate health support, Urological function, Anti-aging potential. Khavinson bioregulator peptide for prostate health. Limited Western clinical data.

How does PROSTAMAX work?

Bioregulator peptide targeting prostate tissue gene expression, potentially supporting normal prostate function and cellular maintenance.